Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,272 | 12,226 | 13,155 | 12,960 | 3,801 |
| Marketable Securities | 172 | 172 | 173 | 473 | N/A |
| Receivables | 3,784 | 3,592 | 4,292 | 3,414 | 3,383 |
| Other current assets | 0 | 0 | 0 | 966 | 1,113 |
| TOTAL | $14,411 | $17,168 | $18,453 | $17,814 | $8,297 |
| Non-Current Assets | |||||
| PPE Net | 4,195 | 4,813 | 4,521 | 4,816 | 4,853 |
| Other Non-Current Assets | 8,865 | 8,392 | 9,151 | 10,121 | 9,808 |
| TOTAL | $13,060 | $13,205 | $13,672 | $14,937 | $14,662 |
| Total Assets | $27,472 | $30,373 | $32,125 | $32,751 | $22,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,943 | 2,744 | 2,652 | 4,473 |
| Accounts payable and accrued liabilities | 2,698 | 2,669 | 2,655 | 2,881 | 4,115 |
| Other current liabilities | N/A | N/A | 294 | 166 | 68 |
| TOTAL | $2,698 | $4,612 | $5,693 | $5,699 | $8,656 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,751 | 2,213 |
| Other Non-Current Liabilities | 85 | 1,306 | 1,592 | 0 | 0 |
| TOTAL | $85 | $1,306 | $1,592 | $1,751 | $2,213 |
| Total Liabilities | $2,783 | $5,919 | $7,285 | $7,451 | $10,869 |
| Shareholders' Equity | |||||
| Retained earnings | -41 | -137 | -121 | -274 | 1,442 |
| TOTAL | $24,689 | $24,454 | $24,840 | $25,301 | $12,089 |
| Total Liabilities And Equity | $27,472 | $30,373 | $32,125 | $32,751 | $22,959 |